Patents by Inventor Paul K. WOTTON

Paul K. WOTTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hazardous agent injection system
    Patent number: 9750881
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: September 5, 2017
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous Agent Injection System
    Publication number: 20170043093
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: August 22, 2016
    Publication date: February 16, 2017
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20170043103
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 17, 2016
    Publication date: February 16, 2017
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20170007621
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: February 19, 2015
    Publication date: January 12, 2017
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. WOTTON, Hermanus L. JOOSTE, Kaushik J. DAVE, Jon JAFFE
  • Prefilled Syringes and Kits Thereof
    Publication number: 20160303311
    Abstract: The present disclosure relates, in part, to a kit including at least two prefilled syringes. The first prefilled syringe includes a dose of a hazardous agent in a first volume of a pharmaceutical composition comprising a pharmaceutically acceptable solvent.
    Type: Application
    Filed: June 27, 2016
    Publication date: October 20, 2016
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, Kaushik J. Dave, Dominic P. Capone
  • Hazardous agent injection system
    Patent number: 9421333
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: December 24, 2014
    Date of Patent: August 23, 2016
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE
    Publication number: 20160235664
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 7, 2014
    Publication date: August 18, 2016
    Inventors: Paul K. WOTTON, Jonathan JAFF
  • Prefilled syringes and kits thereof
    Patent number: 9393367
    Abstract: The present disclosure relates, in part, to a kit including at least two prefilled syringes. The first prefilled syringe includes a dose of a hazardous agent in a first volume of a pharmaceutical composition comprising a pharmaceutically acceptable solvent.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: July 19, 2016
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Peter L. Sadowski, Kaushik J. Dave, Dominic P. Capone
  • Method Of Achieving Increased Systemic Availability of Methotrexate
    Publication number: 20150297600
    Abstract: Determining that a patient in need of methotrexate requires more systemically available methotrexate than can be obtained by an orally administered dose of methotrexate; and subcutaneously administering a dose of methotrexate to the patient.
    Type: Application
    Filed: April 16, 2015
    Publication date: October 22, 2015
    Inventors: Peter L. SADOWSKI, Kaushik J. DAVE, Paul K. WOTTON, Hermanus L. JOOSTE
  • Prefilled Syringes and Kits Thereof
    Publication number: 20150209512
    Abstract: The present disclosure relates, in part, to a kit including at least two prefilled syringes. The first prefilled syringe includes a dose of a hazardous agent in a first volume of a pharmaceutical composition comprising a pharmaceutically acceptable solvent.
    Type: Application
    Filed: April 3, 2015
    Publication date: July 30, 2015
    Inventors: Paul K. Wotton, Peter Sadowski, Dave J. Kaushik, Dominic Philip Capone
  • Hazardous Agent Injection System
    Publication number: 20150119799
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: December 24, 2014
    Publication date: April 30, 2015
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous agent injection system
    Patent number: 8945063
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: February 3, 2015
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John William Hayes
  • Hazardous Agent Injection System
    Publication number: 20140135303
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John William Hayes
  • METHOD OF DETERMINING AN INJECTED DOSE BASED ON A KNOWN ORAL DOSE
    Publication number: 20140107568
    Abstract: The present disclosure relates to methods of determining dosages of compositions used in injection devices, in view of known oral doses of the same compositions.
    Type: Application
    Filed: November 14, 2012
    Publication date: April 17, 2014
    Inventors: Peter L. Sadowski, Kaushik J. Dave, Paul K. Wotton, Hermanus LeRoux Jooste
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20130303985
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: April 5, 2013
    Publication date: November 14, 2013
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • SUBCUTANEOUS NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF METHOTREXATE
    Publication number: 20130058930
    Abstract: The present application is directed, at least in part, to a method of treating an autoimmune disorder in a subject in need of treatment. In one exemplary embodiment, the method comprises introducing into the subcutaneous tissue of the subject, from a needle assisted jet injection device, a composition comprising methotrexate in a dose ranging from about 5 mg to about 50 mg, wherein the pharmacokinetic profile of said methotrexate, obtained following administration of the methotrexate by the needle assisted jet injection device, is substantially the same as the pharmacokinetic profile of the same dose of methotrexate when administered by an intramuscular injection or a subcutaneous injection. The present invention provides benefits and improvements, including an improved clinical utility, improved therapeutic efficacy, over conventional methods of administering methotrexate.
    Type: Application
    Filed: August 1, 2012
    Publication date: March 7, 2013
    Applicant: ANTARES PHARMA, INC.
    Inventors: Kaushik J. DAVE, Peter L. SADOWSKI, Paul K. WOTTON, John W. HAYES